355 related articles for article (PubMed ID: 27527868)
1. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
[TBL] [Abstract][Full Text] [Related]
2. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs in renal cell carcinoma: A systematic review and clinical implications.
Li M; Wang Y; Cheng L; Niu W; Zhao G; Raju JK; Huo J; Wu B; Yin B; Song Y; Bu R
Oncotarget; 2017 Jul; 8(29):48424-48435. PubMed ID: 28467794
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of a novel lncRNA profile reveals potential prognostic biomarkers in clear cell renal cell carcinoma.
Liu T; Sui J; Zhang Y; Zhang XM; Wu WJ; Yang S; Xu SY; Hong WW; Peng H; Yin LH; Pu YP; Liang GY
Oncol Rep; 2018 Sep; 40(3):1503-1514. PubMed ID: 30015930
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of long non-coding RNAs in clear cell renal cell carcinoma: A meta-analysis.
Wang Y; Li Z; Li W; Zhou L; Jiang Y
Medicine (Baltimore); 2019 Oct; 98(40):e17276. PubMed ID: 31577719
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma.
Zhang HM; Yang FQ; Chen SJ; Che J; Zheng JH
Tumour Biol; 2015 Apr; 36(4):2947-55. PubMed ID: 25480417
[TBL] [Abstract][Full Text] [Related]
8. A long non-coding RNA signature to improve prognostic prediction in clear cell renal cell carcinoma.
Zhang J; Zhang X; Piao C; Bi J; Zhang Z; Li Z; Kong C
Biomed Pharmacother; 2019 Oct; 118():109079. PubMed ID: 31351427
[TBL] [Abstract][Full Text] [Related]
9. Long Non-Coding RNA Emergence During Renal Cell Carcinoma Tumorigenesis.
Liu X; Hao Y; Yu W; Yang X; Luo X; Zhao J; Li J; Hu X; Li L
Cell Physiol Biochem; 2018; 47(2):735-746. PubMed ID: 29794462
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of long noncoding RNA PVT1 predicts unfavorable prognosis in patients with clear cell renal cell carcinoma.
Bao X; Duan J; Yan Y; Ma X; Zhang Y; Wang H; Ni D; Wu S; Peng C; Fan Y; Gao Y; Li X; Chen J; Du Q; Zhang F; Zhang X
Cancer Biomark; 2017 Dec; 21(1):55-63. PubMed ID: 29081406
[TBL] [Abstract][Full Text] [Related]
11. High expression of the long non-coding RNA HEIRCC promotes Renal Cell Carcinoma metastasis by inducing epithelial-mesenchymal transition.
Xiong J; Liu Y; Luo S; Jiang L; Zeng Y; Chen Z; Shi X; Lv B; Tang W
Oncotarget; 2017 Jan; 8(4):6555-6563. PubMed ID: 28030807
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA GIHCG is a potential diagnostic and prognostic biomarker and therapeutic target for renal cell carcinoma.
He ZH; Qin XH; Zhang XL; Yi JW; Han JY
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):46-54. PubMed ID: 29364470
[TBL] [Abstract][Full Text] [Related]
13. High expression of long non-coding RNA ATB is associated with poor prognosis in patients with renal cell carcinoma.
Qi JJ; Liu YX; Lin L
Eur Rev Med Pharmacol Sci; 2017 Jun; 21(12):2835-2839. PubMed ID: 28682434
[TBL] [Abstract][Full Text] [Related]
14. Identification of long-non coding RNA UCA1 as an oncogene in renal cell carcinoma.
Li Y; Wang T; Li Y; Chen D; Yu Z; Jin L; Ni L; Yang S; Mao X; Gui Y; Lai Y
Mol Med Rep; 2016 Apr; 13(4):3326-34. PubMed ID: 26935146
[TBL] [Abstract][Full Text] [Related]
15. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
Rashedi S; Mardani M; Rafati A; Khavandi MM; Mohammadi F; Javanshir S; Sarallah R; Dolatshahi M; Sabahi M; Azadnajafabad S; Tavolinejad H; Rezaei N
J Clin Lab Anal; 2022 Oct; 36(10):e24670. PubMed ID: 35989533
[TBL] [Abstract][Full Text] [Related]
16. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
Pu Z; Wang Q; Xie H; Wang G; Hao H
Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of long noncoding RNA MALAT1 in various carcinomas: evidence from nine studies.
Xue Y; Teng YQ; Zhou JD; Rui YJ
Tumour Biol; 2016 Jan; 37(1):1211-5. PubMed ID: 26282005
[TBL] [Abstract][Full Text] [Related]
18. Abnormally Expressed Long Non-Coding RNAs in Nasopharyngeal Carcinoma: a Meta-Analysis.
Xia L; Zhang W; Zhu L; Yu G
Clin Lab; 2018 Apr; 64(4):585-595. PubMed ID: 29739093
[TBL] [Abstract][Full Text] [Related]
19. Characterization of long non-coding RNA expression profiles in lymph node metastasis of early-stage cervical cancer.
Shang C; Zhu W; Liu T; Wang W; Huang G; Huang J; Zhao P; Zhao Y; Yao S
Oncol Rep; 2016 Jun; 35(6):3185-97. PubMed ID: 27035672
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of abnormally expressed lncRNAs in ovarian carcinoma: a systematic review and meta-analysis.
Luo P; Liu XF; Wang YC; Li ND; Liao SJ; Yu MX; Liang CZ; Tu JC
Oncotarget; 2017 Apr; 8(14):23927-23936. PubMed ID: 28118613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
